Pulsed estrogen therapy: Pharmacokinetics of intranasal 17-beta-estradiol (S21400) in postmenopausal women and comparison with oral and transdermal formulations

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 24, Issue 3, 1999, Pages 265-271

  Devissaguet, Jean Philippe ^a,d   Brion, N ^b   Lhote, O ^c   Deloffre, P ^c  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b Unit of Clinical Pharmacology   (France)

^c INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^d UNIV PARIS SUD   (France)

Author keywords

Estradiol; Estrone; Intranasal; Pharmacokinetics; Postmenopausal

Indexed keywords

ESTRADIOL; ESTROFEM; ESTRONE; S 21400; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG FORMULATION; FEMALE; HUMAN; HUMAN EXPERIMENT; POSTMENOPAUSE; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; TABLET;

EID: 0033370270     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03190030     Document Type: Article

References (23)

1. Hargrove J.T., Eisenberg E. (1995) : Menopause. Med. Clin. North Am., 79: 1337-1356.
2. Lievertz R.W. (1987) : Pharmacology and pharmacokinetics of estrogens. Am. J. Obstet. Gynecol., 156: 1289-1293.
3. Judd H.L. (1987) : Oestrogen replacement therapy: physiological considerations and new applications. Baillièrse's Clin. Endocrinol. Metab., 1, 177-206.
4. Kuhnz W., Gansau C., Mahler M. (1993): Pharmacokinetics of estradiol, free and total estrone, in young women following single intravenous and oral administration of 17β-estradiol. Arzneimittelforschung, 43: 966-973.
5. Steingold K.A., Laufer L., Chetkowski R.J. et al. (1985) : Treatment of hot flushes with transdermal estradiol treatment. J. Clin. Endocrinol. Metab., 61: 627-632.
6. Selby P.L., McGarricle H.H.G., Peacock M. (1989) : Comparison of the effects of oral and transdermal oestradiol administration on oestrogen metabolism, protein synthesis, gonadotrophin release, bone turnover and climacteric symptoms in postmenopausal women. Clin. Endocrinol., 30: 241-249.
7. McBurney E.I., Noel S.B., Collins J.H. (1989) : Contact dermatitis to transdermal estradiol system. J. Am. Acad. Dermatol., 20: 508-510.
8. Hermens W.A., Beider C.W., Merkus J.M., Hooymans P.M., Verhoef J., Merkus F.W. (1991) : Intranasal estradiol administration to oophorectomized women. Eur. J. Obstet. Gynecol. Reprod. Biol., 40: 35-41.
9. Peron P.G., Cladwell B.V. (Eds) (1970) : Immunological methods in steroid determination. New York: Century-Crafts, 87-112.
10. Toutain P.L. (1995) : QL-KINTOOL version 3.1.. Pharmacokinetic software. Qualilab, 72, Quai du Châtelet, 45000 Orleans, France.
11. Yamaoka K., Nakagawa T., Uno T. (1978) : Application of Akaike's Information Criterion (AIC) in the evaluation of linear pharmacokinetic equations. J. Pharmacokinet. Biopharm., 6: 165-175.
12. Berner B., John V.A. (1994) : Pharmacokinetic characterisation of transdermal delivery systems. Clin. Pharmacokinet., 26: 121-134.
13. Marty J.P. (1996) : New trends in transdermal technologies: development of the skin patch, Menorest®. Int. J. Gynecol. Obstet, 52: S17-S20.
14. Hankinson S.E., Willett W.C., Manson J.E. et al. (1995) : Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J. Natl Cancer Inst., 87: 1297-1302.
15. Müller P., Botta L., Ezzet F. (1996) : Bioavailability of estradiol from a new matrix and a conventional reservoir-type transdermal therapeutic system. Eur. J. Clin. Pharmacol, 51: 327-330.
16. Scott R.T., Ross B., Anderson C., Archer D.F. (1991) : Pharmacokinetics of percutaneous estradiol: a crossover study using a gel and a transdermal system in comparison with oral micronized estradiol. Obstet. Gynecol., 77 : 758-764.
17. Marty J-P. (1996) : Menorest: technical development and pharmacokinetic profile. Eur. J. Obstet. Gynecol, 64: S29-S33.
18. Fink B.J., Christensen M.S. (1981) : Bioavailability of oestradiol and oestriol administered orally to oophorectomized women. Maturitas, 3: 289-294.
19. Studd J., Pornel B., Marton I. et al. (1999) : Dose-response study of the efficacy and acceptability of intra-nasal 17-β estradiol. Lancet, 353: 1574-1578.
20. Kronenberg F. (1990) : Hot flushes: epidemiology and physiology. Ann. N. Y. Acad. Sci., 592: 52-86.
21. Kuttenn F. (1993) : Traitement de la ménopause. Rev. Prat. (Paris), 43: 2593-2595.
22. Lindsay R., Dempster D.W., Jordan V.C. (Eds) (1997) : Estrogens and antiestrogens: basic and clinical aspects. Philadelphia: Lapincott-Raven, 43-62.
23. Lobo R.A., Cassidenti D.L. (1992) : Pharmacokinetics of oral 17β-estradiol. J. Reprod. Med., 37: 77-83.